Search Results - "Craig, I"

Refine Results
  1. 1

    In vitro models for the study of osteoarthritis by Johnson, Craig I., Argyle, David J., Clements, Dylan N.

    Published in The veterinary journal (1997) (01-03-2016)
    “…•No in vitro model of osteoarthritis has been validated against the native disease.•Cytokine and compression models are most commonly used.•Cytokine based…”
    Get full text
    Journal Article
  2. 2

    Water-Splitting Electrocatalysis in Acid Conditions Using Ruthenate-Iridate Pyrochlores by Sardar, Kripasindhu, Petrucco, Enrico, Hiley, Craig I., Sharman, Jonathan D. B., Wells, Peter P., Russell, Andrea E., Kashtiban, Reza J., Sloan, Jeremy, Walton, Richard I.

    Published in Angewandte Chemie International Edition (06-10-2014)
    “…The pyrochlore solid solution (Na0.33Ce0.67)2(Ir1−xRux)2O7 (0≤x≤1), containing B‐site RuIV and IrIV is prepared by hydrothermal synthesis and used as a…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    MAOA, maltreatment, and gene-environment interaction predicting children's mental health : new evidence and a meta-analysis by KIM-COHEN, J, CASPI, A, TAYLOR, A, WILLIAMS, B, NEWCOMBE, R, CRAIG, I. W, MOFFITT, T. E

    Published in Molecular psychiatry (01-10-2006)
    “…Previous research on adults has shown that a functional polymorphism in the promoter region of the monoamine oxidase A (MAOA) gene moderates the impact of…”
    Get full text
    Journal Article
  6. 6

    EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION by Coleman, Craig I., Turpie, Alexander, Bunz, Thomas J., Sood, Nitesh

    “…Rates of stroke/systemic embolism (SSE), ischemic stroke and major bleeding were compared. Apixaban, dabigatran and rivaroxaban were each associated with a…”
    Get full text
    Journal Article
  7. 7

    Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States by Coleman, Craig I, Tangirala, Muralikrishna, Evers, Thomas

    Published in PloS one (21-06-2016)
    “…A retrospective cohort analysis of the US MarketScan claims databases was performed to compare persistence and discontinuation rates between the vitamin K…”
    Get full text
    Journal Article
  8. 8

    pollinator shift explains floral divergence in an orchid species complex in South Africa by Peter, Craig I, Johnson, Steven D

    Published in Annals of botany (01-01-2014)
    “…Background and AimsFloral diversification driven by shifts between pollinators has been one of the key explanations for the radiation of angiosperms. According…”
    Get full text
    Journal Article
  9. 9

    Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack by Coleman, Craig I, Peacock, W Frank, Bunz, Thomas J, Alberts, Mark J

    Published in Stroke (1970) (01-08-2017)
    “…BACKGROUND AND PURPOSE—Limited real-world data exist comparing each non–vitamin K antagonist oral anticoagulant (NOAC) to warfarin in patients with nonvalvular…”
    Get full text
    Journal Article
  10. 10

    The current state of play on the molecular genetics of depression by Cohen-Woods, S, Craig, I W, McGuffin, P

    Published in Psychological medicine (01-04-2013)
    “…It has been well established that both genes and non-shared environment contribute substantially to the underlying aetiology of major depressive disorder…”
    Get more information
    Journal Article
  11. 11

    Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes by Phung, Olivia J, Scholle, Jennifer M, Talwar, Mehak, Coleman, Craig I

    “…CONTEXT Metformin is the recommended initial drug therapy for patients with type 2 diabetes mellitus (DM). However, the optimal second-line drug when metformin…”
    Get full text
    Journal Article
  12. 12

    Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis by Weeda, Erin R, Coleman, Craig I, McHorney, Colleen A, Crivera, Concetta, Schein, Jeff R, Sobieraj, Diana M

    Published in International journal of cardiology (01-08-2016)
    “…Abstract Background Most cardiovascular diseases require patients to take one or more chronic medications, often administered multiple times daily. We sought…”
    Get full text
    Journal Article
  13. 13

    Induction of IgG2 and IgG4 B‐cell memory following sublingual immunotherapy for ryegrass pollen allergy by Heeringa, Jorn J., McKenzie, Craig I., Varese, Nirupama, Hew, Mark, Bakx, Amy T. C. M., Aui, Pei M., Rolland, Jennifer M., O’Hehir, Robyn E., Zelm, Menno C.

    Published in Allergy (Copenhagen) (01-05-2020)
    “…Background While treatment for atopic rhinitis is aimed mostly to relieve symptoms, only allergen‐specific immunotherapy (AIT) is targeted to modify the…”
    Get full text
    Journal Article
  14. 14

    Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation by Martinez, Brandon K., Sood, Nitesh A., Bunz, Thomas J., Coleman, Craig I.

    Published in Journal of the American Heart Association (17-04-2018)
    “…Background Frailty predicts poorer outcomes and decreased anticoagulation use in patients with nonvalvular atrial fibrillation. We sought to assess the…”
    Get full text
    Journal Article
  15. 15

    Worsening of kidney function in patients with atrial fibrillation and chronic kidney disease: evidence from the real-world CALLIPER study by Vaitsiakhovich, Tatsiana, Coleman, Craig I., Kleinjung, Frank, Vardar, Burcu, Schaefer, Bernhard

    Published in Current medical research and opinion (03-06-2022)
    “…Evidence is needed on the impact of anticoagulation therapy on kidney function in patients with atrial fibrillation (AF). The objective of this analysis, which…”
    Get full text
    Journal Article
  16. 16

    Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis by Mearns, Elizabeth S, Sobieraj, Diana M, White, C Michael, Saulsberry, Whitney J, Kohn, Christine G, Doleh, Yunes, Zaccaro, Eric, Coleman, Craig I

    Published in PloS one (28-04-2015)
    “…When first line therapy with metformin is insufficient for patients with type 2 diabetes (T2D), the optimal adjunctive therapy is unclear. We assessed the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors by Miao, Benjamin, Hernandez, Adrian V, Alberts, Mark J, Mangiafico, Nicholas, Roman, Yuani M, Coleman, Craig I

    Published in Journal of the American Heart Association (21-01-2020)
    “…Background There is a paucity of contemporary data estimating the incidence of major adverse cardiovascular events (MACE) in patients with established…”
    Get full text
    Journal Article
  20. 20